Clinical Trials in Chandler, Arizona

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

NCT ID: NCT06245408

This clinical trial is studying a new treatment called dazodalibep for patients with Sjögren's Syndrome (SS), specifically those who experience moderate to severe symptoms. The main goal is to see ...

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

NCT ID: NCT06252649

This clinical trial is studying a new treatment approach for patients with metastatic colorectal cancer that has a specific genetic change known as the KRAS p.G12C mutation. Researchers want to see...

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

NCT ID: NCT06585787

The ADEPT-4 clinical trial is studying a new treatment called KarXT for individuals with Alzheimer's Disease (AD) who are experiencing psychosis, which includes symptoms like hallucinations or delu...

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT ID: NCT06617325

This clinical trial is studying a new treatment called dapirolizumab pegol (DZP) for people with moderately to severely active systemic lupus erythematosus (SLE), a chronic autoimmune disease that ...

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

NCT ID: NCT07043400

This clinical trial is studying a cancer treatment called tislelizumab for adults with advanced stomach cancer or cancer where the stomach meets the esophagus. The goal is to compare two ways of gi...

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

NCT ID: NCT05211895

This clinical trial is studying the effects of two medications, durvalumab and domvanalimab, on adults with Stage III non-small cell lung cancer (NSCLC) that cannot be surgically removed. The trial...

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

NCT ID: NCT06465186

This clinical trial is studying a new medicine called efinopegdutide to see if it can help people with a liver disease known as metabolic dysfunction-associated steatohepatitis (MASH), which is cau...

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

NCT ID: NCT06868264

The C-BEYOND clinical trial is studying two different treatment options for adults with chronic Hepatitis C virus (HCV) infection: BEM/RZR and SOF/VEL. The main goal is to find out which treatment ...

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

NCT ID: NCT03891446

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

NCT ID: NCT04743765

The HIP ATTACK-2 trial is a study designed to see if having surgery sooner for hip fractures in patients who also have heart problems (specifically, an increase in heart injury markers) can help th...

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT04928846

This clinical trial is studying a new treatment called telisotuzumab vedotin for adults with non-small cell lung cancer (NSCLC) who have already received treatment in the past. Researchers want to ...

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT ID: NCT05395481

This clinical trial is studying a new medication called LY3849891 to see if it is safe and how well it works for people with nonalcoholic fatty liver disease, particularly those who have a specific...

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

NCT ID: NCT06568042

This clinical trial is looking at a new treatment called LY3848575 to see how safe and effective it is for people experiencing painful nerve pain, specifically in the feet and legs. This kind of pa...

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06598943

This clinical trial is looking at two medications, eltrekibart and mirikizumab, to see how safe and effective they are for adults with moderately to severely active ulcerative colitis (UC). Ulcerat...

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

NCT ID: NCT06603571

This clinical trial is studying a new treatment called LY3841136, both alone and with another medication called Tirzepatide, to help manage weight in adults who are overweight or have obesity and a...

A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

NCT ID: NCT06653153

The TRAILRUNNER-ALZ 3 study is looking at a new drug called Remternetug (LY3372993) to see if it can help people with early Alzheimer's disease. The main goal of the trial is to find out if this dr...

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

NCT ID: NCT06709014

This clinical trial is studying a medication called buntanetap/Posiphen to see if it can help improve thinking and daily functioning in adults aged 55 to 85 who have early Alzheimer’s disease (AD)....

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

NCT ID: NCT06846541

This clinical trial is studying a medication called ESK-001 to see how safe it is when taken for a long time by people with moderate to severe plaque psoriasis, a skin condition that causes red, sc...

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

NCT ID: NCT04929210

This clinical trial is studying a medication called guselkumab to see how well it works for people with active psoriatic arthritis (PsA) that affects the spine and pelvis. The goal is to find out i...